Startup Axonics Modulation Technologies brings in close to $17.3 million in equity funding for its next-generation neuromodulation technology to treat overactive bladder and other conditions.
Axonics Modulation Technologies said it raised nearly $17.3 million in an equity financing as it develops next-generation neuromodulation technology to treat various medical conditions.
The California company disclosed the funding in a recent regulatory filing that does not name specific investors.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ERTSPR
Cap comentari:
Publica un comentari a l'entrada